0001942327-22-000001.txt : 20220817 0001942327-22-000001.hdr.sgml : 20220817 20220817160859 ACCESSION NUMBER: 0001942327-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 EFFECTIVENESS DATE: 20220817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GeneVentiv Therapeutics, Inc. CENTRAL INDEX KEY: 0001942327 IRS NUMBER: 853580283 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-456181 FILM NUMBER: 221174101 BUSINESS ADDRESS: STREET 1: 150 FAYETTEVILLE STREET STREET 2: SUITE 2300 CITY: RALEIGH STATE: NC ZIP: 27601 BUSINESS PHONE: 919-529-3352 MAIL ADDRESS: STREET 1: 150 FAYETTEVILLE STREET STREET 2: SUITE 2300 CITY: RALEIGH STATE: NC ZIP: 27601 D 1 primary_doc.xml X0708 D LIVE 0001942327 GeneVentiv Therapeutics, Inc. 150 FAYETTEVILLE STREET SUITE 2300 RALEIGH NC NORTH CAROLINA 27601 919-529-3352 DELAWARE None None Corporation true 2020 Damon Race 150 FAYETTEVILLE STREET SUITE 2300 RALEIGH NC NORTH CAROLINA 27601 Executive Officer Director Richard Limehouse 150 FAYETTEVILLE STREET SUITE 2300 RALEIGH NC NORTH CAROLINA 27601 Director Biotechnology Decline to Disclose 06b false 2022-07-29 false true false 0 2000000 1399993 600007 false 1 0 0 0 None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3. false GeneVentiv Therapeutics, Inc. /s/ Damon R. Race Damon R. Race President and Chief Executive Officer 2022-08-17